Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII).

Academic Article

Abstract

  • OBJECTIVE: To examine the predictors of time to premature gonadal failure (PGF) in patients with systemic lupus erythematosus from LUMINA, a multiethnic US cohort. METHODS: PGF was defined according to the SLICC Damage Index (SDI). Factors associated with time to PGF occurrence were examined by univariable and multivariable Cox proportional hazards regression analyses: three models according to cyclophosphamide use, at T0 (model 1), over time (model 2) and the total number of intravenous pulses (model 3). RESULTS: Thirty-seven of 316 women (11.7%) developed PGF (19 Texan-Hispanics, 14 African-Americans, four Caucasians and no Puerto Rican-Hispanics). By multivariable analyses, older age at T0 (hazards ratio (HR) = 1.10-1.14; 95% CI 1.02-1.05 to 1.19-1.23) and disease activity (Systemic Lupus Activity Measure-Revised) in all models (HR = 1.22-1.24; 95% CI 1.10-1.12 to 1.35-1.37), Texan-Hispanic ethnicity in models 2 and 3 (HR = 4.06-5.07; 95% CI 1.03-1.25 to 15.94-20.47) and cyclophosphamide use in models 1 and 3 (1-6 pulses) (HR = 4.01-4.65; 95% CI 1.55-1.68 to 9.56-13.94) were predictors of a shorter time to PGF. CONCLUSIONS: Disease activity and Texan-Hispanic ethnicity emerged as predictors of a shorter time to PGF while the associations with cyclophosphamide use and older age were confirmed. Furthermore, cyclophosphamide induction therapy emerged as an important determinant of PGF.
  • Published In

    Keywords

  • Acute Disease, Adult, African Americans, Age Factors, Cyclophosphamide, European Continental Ancestry Group, Female, Hispanic Americans, Humans, Immunosuppressive Agents, Longitudinal Studies, Lupus Erythematosus, Systemic, Menopause, Premature, Multivariate Analysis, Prognosis, Proportional Hazards Models, Risk
  • Digital Object Identifier (doi)

    Author List

  • González LA; McGwin G; Durán S; Pons-Estel GJ; Apte M; Vilá LM; Reveille JD; Alarcón GS; LUMINA Study Group
  • Start Page

  • 1170
  • End Page

  • 1173
  • Volume

  • 67
  • Issue

  • 8